Robert Chiaramonte
Urology · Clinton, MDNPI 1508817412
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 142 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 14.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,191 and has fallen 98.7% since, to $16 in 2024. That places this record below the midpoint for urology clinicians in MD, where the typical reported total is $4,190.
Across 142 payments — averaging $17.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$366
- Astellas Pharma US Inc$317
- Johnson & Johnson$305
- Pfizer$245
- Ferring Pharmaceuticals Inc.$180
- Bayer$142
- plus $968 from 22 others
What the payments were for
- Food & beverage$2,514100%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 22 | $366 |
| Astellas Pharma US Inc | 18 | $317 |
| Johnson & Johnson(2 entities) | 19 | $305 |
| Pfizer | 16 | $245 |
| Ferring Pharmaceuticals Inc. | 13 | $180 |
| Bayer | 6 | $142 |
| Endo Pharmaceuticals Inc. | 8 | $140 |
| Blue Earth Diagnostics | 6 | $121 |
| Dendreon Pharmaceuticals LLC | 4 | $93 |
| Amgen | 4 | $84 |
| Urogen Pharma, Inc. | 1 | $76 |
| Myovant Sciences Inc. | 3 | $64 |
| Boston Scientific | 2 | $51 |
| Myriad Genetic Laboratories, Inc. | 3 | $48 |
| Coloplast | 2 | $32 |
| Foundation Medicine, Inc. | 2 | $30 |
| Clarus Therapeutics Inc. | 2 | $29 |
| Rochester Medical Corporation | 1 | $28 |
| Therapeuticsmd, Inc. | 1 | $21 |
| AstraZeneca | 1 | $20 |
| Tolmar Pharmaceuticals, Inc. | 1 | $19 |
| Dentsply IH Inc. | 1 | $19 |
| Travere Therapeutics, Inc. | 1 | $17 |
| Antares Pharma, Inc. | 1 | $17 |
| Avadel Specialty Pharmaceuticals, LLC | 1 | $17 |
| Dentsply IH AB | 1 | $16 |
| Urovant Sciences Inc | 1 | $15 |
| Metuchen Pharmaceuticals | 1 | $11 |
How this compares
$2,522 in reported general payments places this provider in the 40th percentile of 274 urology providers in Maryland.
Other urology in Clinton
- Matthew AllawayCumberland$20.6M
- Benjamin LowentrittBaltimore$549K
- Julio DavalosGlen Burnie$490K
- Sankar KausikBel Air$375K
- Laura GiustoOwings Mills$367K
- Amin HeratiBaltimore$160K
- Rian DicksteinHanover$144K
- Max KatesBaltimore$139K
- Arthur BurnettBaltimore$132K
- Aaron WeinbergBaltimore$106K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.